XIAP and hematologic disorder: Should reverse immunology approaches be further employed for the discovery of MiHA relevant to the immunotherapy of hematologic malignancies, it will be essential that discovery efforts are focused on those candidate MiHA polymorphisms with allele frequencies that ensure frequent donor/recipient disparity.